Advances in the Management of Moderate-to-Severe Atopic Dermatitis

Program Overview

For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam’s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.

Credit Expired

Target Audience

The target audience for this activity is US-based dermatologists, allergists, and immunologists, as well as NPs and PAs that diagnose and manage atopic dermatitis (AD). Primary care clinicians will also be included as a secondary audience.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Apply current principles of pathophysiology of atopic dermatitis (AD) and the concept of atopic march to therapeutic approaches to disease management
Develop treatment plans for patients with AD that reflect evidence-based guidelines, use of new and emerging therapeutic options, assessment of treatment response, and strategies to optimize short-term control and long-term management of the disease
Assess for and manage quality-of-life issues and psychosocial comorbidities in patients with AD
Utilize shared decision making and develop treatment plans that will result in high levels of adherence and better patient outcomes

Activity Faculty

Peter A. Lio, MD (Chair)

Assistant Professor, Clinical Dermatology and Pediatrics
Northwestern University
Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital
Chicago, IL

Mark Boguniewicz, MD

Professor, Division of Allergy-Immunology
Department of Pediatrics
National Jewish Health and University of Colorado School of Medicine
Denver, CO

Eric L. Simpson, MD, MCR

Professor, Dermatology
Director, Clinical Research
Department of Dermatology
Oregon Health & Science University
Portland, OR

Featured RMEI CE Activities – Earn CE Credit(s)

Advances in the Management of Moderate-to-Severe Atopic Dermatitis

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Peter A. Lio, MD (Chair)

Mark Boguniewicz, MD

Eric L. Simpson, MD, MCR

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe